Zymofix SA
12.4 FTEZymofix reported total assets of €2.41m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026), with 12.4 full-time equivalents.
The score of Zymofix shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Total assets +5134 % Headcount (avg FTE) +854 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Zymofix's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
Zymofix's financial analysis
- Solvency65.5%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Zymofix
Zymofix's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0788.847.055
- VAT number
- BE0788847055
- Peppol
- Registered · 0208:0788847055 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 25 Jul 2022
- Registered office
- 9032 Ghent
- Size
- Small · 12.4 FTE
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Zymofix (SA) has been based in Ghent since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 636,911 € and equity of €1.58m; its revenue is not published. With 12.4 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 65.5%, above the median of its sector (61.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Zymofix
Companies in the same business, of comparable size and area, outside its group.
- BiometrIQ Research and experimental development on natural sciences and engineering Kortrijk · balance sheet €1.65m
- Santero Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.15m
- Cancer State Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.96m
- Nexelis Europe Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.65m
- Protealis Research and experimental development on natural sciences and engineering Ghent · balance sheet €11.1m
- Puxano Research and experimental development on natural sciences and engineering Ghent · balance sheet €2.43m
- MSI-Dfat EU Research and experimental development on natural sciences and engineering Jodoigne · balance sheet €1.08m
- Syscade Research and experimental development on natural sciences and engineering Tournai · balance sheet €2.26m
Frequently asked questions about Zymofix
What is the revenue of Zymofix?
Zymofix files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Zymofix?
In Belgium, the VAT number is the company number prefixed with BE: BE0788847055 for Zymofix, if the company is VAT-registered. Its company number (CBE) is 0788.847.055.
Where is the registered office of Zymofix?
According to the CBE register, the registered office of Zymofix is in 9032 Ghent.
What is the equity of Zymofix?
At the close of the 2025 financial year, the equity of Zymofix amounts to 1,581,088 €, a solvency of 65.5% of total assets.
How many people work at Zymofix?
12.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Zymofix?
The register lists 9 active mandates at Zymofix. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Zymofix
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →